We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.84B
AUM Growth
Cap. Flow
+$8.61B
Cap. Flow %
97.4%
Top 10 Hldgs %
15.75%
Holding
2,221
New
2,220
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$266M
2
MSFT icon
Microsoft
MSFT
+$196M
3
AMZN icon
Amazon
AMZN
+$136M
4
META icon
Meta Platforms (Facebook)
META
+$130M
5
JNJ icon
Johnson & Johnson
JNJ
+$116M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 17.06%
2 Technology 16.26%
3 Healthcare 12.6%
4 Industrials 11.39%
5 Consumer Discretionary 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNR
1701
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$306K ﹤0.01%
+40,485
New +$338K
CUDA
1702
DELISTED
Barracuda Networks, Inc.
CUDA
$306K ﹤0.01%
+11,138
New +$276K
AHRT
1703
AH Realty Trust
AHRT
$501M
$305K ﹤0.01%
+19,662
New +$292K
CAMP
1704
DELISTED
CalAmp Corp.
CAMP
$305K ﹤0.01%
+619
New +$320K
APTS
1705
DELISTED
Preferred Apartment Communities, Inc.
APTS
$304K ﹤0.01%
+15,013
New +$309K
CWEN.A
1706
DELISTED
Clearway Energy Class A
CWEN.A
$303K ﹤0.01%
+16,087
New +$302K
GPRE icon
1707
Green Plains
GPRE
$1.09B
$303K ﹤0.01%
+17,956
New +$316K
ECHO
1708
DELISTED
Echo Global Logistics, Inc.
ECHO
$302K ﹤0.01%
+10,797
New +$259K
STAA icon
1709
STAAR Surgical
STAA
$1.24B
$301K ﹤0.01%
+19,419
New +$289K
GHDX
1710
DELISTED
Genomic Health, Inc.
GHDX
$301K ﹤0.01%
+8,810
New +$281K
GTS
1711
DELISTED
Triple-S Management Corporation
GTS
$300K ﹤0.01%
+12,691
New +$309K
CARB
1712
DELISTED
Carbonite Inc
CARB
$300K ﹤0.01%
+11,965
New +$278K
MSEX icon
1713
Middlesex Water
MSEX
$1.1B
$299K ﹤0.01%
+7,497
New +$323K
ANGO icon
1714
AngioDynamics
ANGO
$651M
$297K ﹤0.01%
+17,852
New +$305K
ATRC icon
1715
AtriCure
ATRC
$2.18B
$297K ﹤0.01%
+16,270
New +$322K
AXDX
1716
DELISTED
Accelerate Diagnostics
AXDX
$297K ﹤0.01%
+1,135
New +$266K
TTEC icon
1717
TTEC Holdings
TTEC
$84.2M
$297K ﹤0.01%
+7,377
New +$304K
MED icon
1718
Medifast
MED
$130M
$296K ﹤0.01%
+4,237
New +$281K
QUAD icon
1719
Quad
QUAD
$502M
$296K ﹤0.01%
+13,076
New +$297K
IMGN
1720
DELISTED
Immunogen Inc
IMGN
$295K ﹤0.01%
+46,019
New +$284K
LCI
1721
DELISTED
Lannett Company, Inc.
LCI
$295K ﹤0.01%
+3,178
New +$310K
VRS
1722
DELISTED
Verso Corporation
VRS
$295K ﹤0.01%
+16,813
New +$161K
GFF icon
1723
Griffon
GFF
$4.84B
$294K ﹤0.01%
+14,438
New +$316K
LORL
1724
DELISTED
Loral Space and Communications, Inc.
LORL
$294K ﹤0.01%
+6,669
New +$312K
FPRX
1725
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$294K ﹤0.01%
+13,422
New +$432K

Similar funds

MetLife Investment Management's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for MetLife Investment Management, which disclosed 2,221 positions worth $8.84B. Its ten largest holdings account for 16% of the portfolio.

Its largest position is Apple: 6,354,396 shares worth $269M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, followed by Technology and Healthcare.

  • MetLife Investment Management's largest Q4 2017 buy was Apple: 6,354,396 shares worth $269M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $8.84B portfolio in Q4 2017.
  • MetLife Investment Management disclosed 2,221 positions in Q4 2017, its first 13F filing on record.

Based on MetLife Investment Management's 13F filing for Q4 2017, filed 15 Feb 2018.